At the time of the last check, shares of EUDA Health Holdings Limited (NASD: EUDA) were trading at $2.00, up 21.21%. There may be some justification to think that recent developments will provide more details on the digital health platform given that EUDA shares rose even in the absence of recent news.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
What has recently happened at EUDA?
EUDA Health (EUDA) recently completed its business combination (the “Business Combination”) with 8i Acquisition 2 Corp. (LAX). LAX is a publicly traded special purpose acquisition company, and EUDA Health is a digital health platform established in Singapore that seeks to achieve better outcomes through individualized healthcare and make healthcare more cheap, accessible, and patient-friendly.
Dr. Kelvin Chen, the founder and CEO of EUDA, has led the combined entity since its inception under the name “EUDA Health Holdings Limited.” Common shares and warrants of the amalgamated business began trading on the Nasdaq Stock Market at the opening of trade on November 18, 2022, with the tickers “EUDA” and “EUDAW,” respectively.
All remaining LAX units were divided into their underlying parts, which are one common share, one redeemable warrant, and one right, upon the conclusion of the Business Combination. One common share could be purchased with every two redeemable warrants, and one common share could be received with every ten rights.
At the LAX stockholders’ special meeting on November 10, 2022, the deal was approved. The unique AI platform from EUDA Health is a game-changer in customized healthcare and at the forefront of promoting real patient empowerment. Due to EUDA’s strong value offering, substantial market potential, and expanding growth prospects, LAX amalgamated with it.
How will EUDA use the combination to its advantage?
The conclusion of that business combination deal marks a significant advancement in EUDA’s aim to improve healthcare outcomes and patient satisfaction while lowering costs and increasing accessibility. EUDA Health (EUDA) will be able to grow its thorough, end-to-end care all through the Asia Pacific area and beyond by becoming public and further improving its platform ecosystem.
